Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria

J.M.A. Wijnands*, A. Boonen, I.C. Arts, P.C. Dagnelie, C.D.A. Stehouwer, S. van der Linden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)


Large epidemiologic studies of gout can improve insight into the etiology, pathology, impact, and management of the disease. Identification of monosodium urate monohydrate crystals is considered the gold standard for diagnosis, but its application is often not possible in large studies. Therefore, under such circumstances, several proxy approaches are used to classify patients as having gout, including ICD coding in several types of databases or questionnaires that are usually based on the existing classification criteria. However, agreement among these methods is disappointing. Moreover, studies use the terms acute, recurrent, and chronic gout in different ways and without clear definitions. Better definitions of the different manifestations and stages of gout may provide better insight into the natural course and burden of disease and can be the basis for valid approaches to correctly classifying patients within large epidemiologic studies.
Original languageEnglish
Pages (from-to)167-174
JournalCurrent Rheumatology Reports
Issue number2
Publication statusPublished - 1 Jan 2011


Dive into the research topics of 'Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria'. Together they form a unique fingerprint.

Cite this